Back

Risk factors for long COVID among healthcare workers, Brazil, 2020

Marra, A. R.; Sampaio, V.; Ozahata, M. C.; da Silva, R. L.; Brito, A.; Bragatte, M.; Kalil, J.; Miraglia, J. L.; Malheiros, D. T.; Guozhang, Y.; Teich, V. D.; Victor, E. d. S.; Pinho, J. R.; Cypriano, A.; Vieira, L. W.; Polonio, M.; de Oliveira, S. M.; Ricardo, V. C.; Maezato, A. M.; Callado, C. Y.; Schettino, G. P.; de Oliveira, K. G.; Santana, R. A.; Malta, F. d. M.; Amgarten, D.; Boechat, A. L.; Kobayashi, T.; Perencevich, E.; Edmond, M. B.; Rizzo, L. V.

2023-01-05 infectious diseases
10.1101/2023.01.03.22284043 medRxiv
Show abstract

ObjectivesWe aimed to determine risk factors for the development of long coronavirus disease (COVID) in healthcare workers (HCWs). MethodsWe conducted a case-control study among HCWs who had confirmed COVID-19 infection working in a Brazilian healthcare system between March 1, 2020 and July 15, 2022. Cases were defined as those having long COVID per the Centers for Disease Control and Prevention definition. Controls were defined as HCWs who had documented COVID-19 infection but did not develop long COVID. Multiple logistic regression was used to assess the association between exposure variables and long COVID during 180 days of follow-up. ResultsOf 7,051 HCWs diagnosed with COVID-19 infection, 1,933 (27.4%) who developed long COVID were compared to 5,118 (72.6%) who did not. The majority of those with long COVID (51.8%) had 3 or more symptoms. Factors associated with development of long COVID were female sex (OR 1.21 [CI95 1.05-1.39]), age (OR 1.01 [CI95 1.00-1.02]), and two or more COVID-19 infections (1.27 [CI95 1.07-1.50]). Those infected with the Delta variant (OR 0.30 [CI95 0.17-0.50]) or the Omicron variant (OR 0.49 [CI95 0.30-0.78]), and those receiving four COVID-19 vaccine doses prior to infection (OR 0.05 [CI95 0.01-0.19]) were significantly less likely to develop long COVID. ConclusionsLong COVID can be prevalent among HCWs. We found that acquiring more than one COVID-19 infection was a major risk factor for long COVID, while maintenance of immunity via vaccination was highly protective.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Clinical Microbiology and Infection
60 papers in training set
Top 0.1%
17.5%
2
PLOS ONE
4510 papers in training set
Top 17%
10.5%
3
Epidemiology and Infection
84 papers in training set
Top 0.1%
8.4%
4
BMC Infectious Diseases
118 papers in training set
Top 0.8%
4.0%
5
Open Forum Infectious Diseases
134 papers in training set
Top 0.3%
4.0%
6
Clinical Infectious Diseases
231 papers in training set
Top 1%
3.6%
7
Infectious Diseases
14 papers in training set
Top 0.1%
3.1%
50% of probability mass above
8
Vaccines
196 papers in training set
Top 0.8%
2.7%
9
Journal of Medical Virology
137 papers in training set
Top 1%
2.6%
10
Scientific Reports
3102 papers in training set
Top 47%
2.4%
11
JAMA Network Open
127 papers in training set
Top 2%
2.1%
12
Eurosurveillance
80 papers in training set
Top 0.6%
1.9%
13
BMJ Open
554 papers in training set
Top 9%
1.7%
14
Occupational and Environmental Medicine
15 papers in training set
Top 0.1%
1.7%
15
Journal of Infection
71 papers in training set
Top 2%
1.5%
16
International Journal of Infectious Diseases
126 papers in training set
Top 2%
1.5%
17
Frontiers in Medicine
113 papers in training set
Top 4%
1.3%
18
BMC Medicine
163 papers in training set
Top 5%
1.0%
19
BMC Public Health
147 papers in training set
Top 5%
1.0%
20
Viruses
318 papers in training set
Top 4%
0.9%
21
JMIR Public Health and Surveillance
45 papers in training set
Top 3%
0.9%
22
The Journal of Infectious Diseases
182 papers in training set
Top 4%
0.9%
23
Travel Medicine and Infectious Disease
15 papers in training set
Top 0.7%
0.7%
24
Frontiers in Public Health
140 papers in training set
Top 8%
0.7%
25
Diagnostics
48 papers in training set
Top 2%
0.7%
26
Public Health
34 papers in training set
Top 2%
0.7%
27
International Journal of Environmental Research and Public Health
124 papers in training set
Top 7%
0.7%
28
Emerging Infectious Diseases
103 papers in training set
Top 3%
0.7%
29
Vaccine
189 papers in training set
Top 2%
0.7%
30
BMJ
49 papers in training set
Top 1%
0.7%